Feds Eye Partial Pretrial Ruling In Regeneron FCA Case
By Lauren Berg · October 2, 2025, 9:48 PM EDT
The government has urged a Massachusetts federal judge to rule that Regeneron Pharmaceuticals "naturally or foreseeably" caused providers to present false claims for its macular degeneration drug Eylea, arguing that it...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login